Biphosphonate-Mediated Gene Vector Delivery from the Metal Surfaces of Stents

Loading...
Thumbnail Image
Penn collection
Departmental Papers (CBE)
Degree type
Discipline
Subject
gene therapy
local delivery
restenosis
Biochemical and Biomolecular Engineering
Chemical Engineering
Engineering
Genetics and Genomics
Materials Science and Engineering
Funder
Grant number
License
Copyright date
Distributor
Related resources
Author
Fishbein, Ilia
Alferiev, Ivan S
Nyanguile, Origene
Gaster, Richard
Wong, Gordon Sek-Yin
Felderman, Howard
Choi, Hoon
Wilensky, Robert L
Contributor
Abstract

The clinical use of metallic expandable intravascular stents has resulted in imporved therapeutic outcomes for coronary artery disease. However, arterial reobstruction after stenting, in-stent restenosis, remains an important problem. Gene therapy to treat in-stent restenosis by using gene vector delivery from the metallic stent surfaces has never been demonstrated. The present studies investigated the hypothesis that metal-biphosphonate binding can enable site-specific gene vector delivery from metal surfaces. Polyallylamine biphosphonate (PAA-BP) was synthesized by using Michael addition methodology. Exposure to aqueous solutions of PAA-BP resulted in the formation of a monomolecular biphosphonate later on metal alloy surfaces (steel, nitinol, and cobalt-chromium), as demonstrated by x-ray photoelectron spectroscopy. Surface-bound PAA-BP enabled adenoviral (Ad) tethering due to covalent thiol-binding of either anti-Ad antibody or a recombinant Ad-receptor protein, D1. In arterial smooth muscle cell cultures, alloy samples configured with surface-tethered Ad were demonstrated to achieve site-specific transduction with a reporter gene, (GFP). Rat carotid stent angioplasties using metal stents exposed to aqueous PAA-BP and derivatized with anti-knob antibody or D1 resulted in extensive localized Ad-GFP expression in the arterial wall. In a separate study with a model therapeutic vector, Ad-inducible nitric oxide synthase (iNOS) attached to the biphosphonate-treated metal stent surface via D1, significant inhibition of restenosis was demonstrated (neointimal/media ration 1.68 ± 0.27 and 3.4 ± 0.35; Ad-iNOS vs. control, P < 0.01). Is is concluded that effective gene vector delivery from metallic stent surfaces can be achieved using this approach.

Advisor
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Publication date
2006-01-01
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation
Collection